Table 2: EFFECTS OF TOTAL NUMBER OF COMORBIDITIES ON DECREASE ED VISITS AFTER WAAP.
|
|||||
Total No. of Comorbidities Per Patient* |
Overall Sample |
Change in ED visits |
Low ed Users |
High ed Users |
p-vALUE |
0-1 Comorbidities |
129 (39.57) |
-0.884 |
104 (80.06) |
25 (19.93) |
0.067 |
2-3 Comorbidities |
112 (30.03) |
-0.134 |
86 (76.79) |
26 (23.21) |
0.001 |
4+ Comorbidities |
85 (26.15) |
-0.741 |
63 (74.12) |
22 (25.89) |
0.364 |
This table demonstrates the relation of decrease in ED visits after WAAP and number of comorbidities present. *p-value signifies whether that range of comorbidity had a relation to the decrease in ED visit, value was calculated with Pearson Chi-square test |